Anti-tumor necrosis factor therapy in Bulgarian pediatric patients with inflammatory bowel disease – an 8-year experience of a referral center


	Rate of deep remission at 12 months.

Part of: Shentova-Eneva RR, Kofinova DR, Baycheva MZh, Hadzhiyski PG, Naydenov HB, Yaneva PG, Lazarova EA (2023) Anti-tumor necrosis factor therapy in Bulgarian pediatric patients with inflammatory bowel disease – an 8-year experience of a referral center. Folia Medica 65(4): 605-611. https://doi.org/10.3897/folmed.65.e84368